NCT00955045View on ClinicalTrials.gov

A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy

PHASE2/PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2002

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions
Parkinson's Disease
Interventions
DRUG

istradefylline

Trial Locations (1)

08540

48 Centers in the US and 4 in Canada, Princeton

Sponsors

Lead Sponsor

Kyowa Kirin, Inc.
All Listed Sponsors
lead

Kyowa Kirin, Inc.

INDUSTRY